PLEASANTON, Calif., Oct. 1, 2024 /PRNewswire/ -- At the Human Cell Atlas General Meeting held September 29-30 in Milan, Italy,…
Micro-Leads Pioneers Medical Breakthrough in a 20 Participant Human Study with HD64, the World's First Spine-ChipSOMERVILLE, MA / ACCESSWIRE /…
JERICHO, N.Y., Oct. 1, 2024 /PRNewswire/ -- The global consulting firm, proudly celebrating 50 transformative years, has gathered a curated collection…
Calyx and Invicro rebrand, usher in a new era of leadership and support to the biopharmaceutical community NOTTINGHAM, England, Sept. 30,…
Multidisciplinary board members bring expertise in drug discovery, clinical development, computational life science, GPCRs and drug formulationBOSTON, Sept. 30, 2024…
– Company is aligned with the FDA on next steps for a 351(k) regulatory pathway to approval for ABP-450 (prabotulinumtoxinA)…
Company to leverage capital and Valor’s expertise for strategic initiatives building market awareness, R&D roadmap, data analysis capabilities, and expanding…
Conference presentation delivers preclinical results demonstrating Ketamir-2 achieves 100% reversal of neuropathic painMIAMI, FL / ACCESSWIRE / September 27, 2024…
PUERTO DE SANTA MARIA, Spain, Sept. 26, 2024 /PRNewswire/ -- In his book, Contact with the Future: The Astonishing Power of…
MINNEAPOLIS , Sept. 26, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that one of its spatial biology brands, Lunaphore,…